To achieve glycemic goals, youth with T1D are increasingly being encouraged to adopt sophisticated diabetes technologies, such as hybrid closed-loop insulin pumps and continuous glucose monitoring (CGM) systems [6, 7]. The gene discussed is INS; the disease is type 1 diabetes mellitus.